Viewing Study NCT05656027

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 5:09 AM
Ignite Modification Date: 2026-05-30 @ 1:00 PM
Study NCT ID: NCT05656027
Status: COMPLETED
Last Update Posted: 2024-12-18
First Post: 2022-12-09
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Phase 3 Evaluation of the Safety and Efficacy of LNZ101 for the Treatment of Presbyopia
Sponsor: LENZ Therapeutics, Inc
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Presbyopia View
None Refractive Error View
None Near Vision View
None Miosis View
None Eye Diseases View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Pharmaceutical Solutions View
None Eye Drops View
None CLARITY View
None Presbyopia View
None Ophthalmic Solutions View
None Miotic View